Indications and outcomes of phototherapeutic keratectomy in the developing world

被引:26
作者
Sharma, Namrata [1 ]
Prakash, Gaurav [1 ]
Sinha, Rajesh [1 ]
Tandon, Radhika [1 ]
Titiyal, Jeewan S. [1 ]
Vajpayee, Rasik B. [2 ]
机构
[1] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, Cornea & Refract Surg Serv, New Delhi 110029, India
[2] Ctr Eye Res Australia, Melbourne, Vic, Australia
关键词
phototherapeutic keratectomy; developing world; bullous keratopathy; corneal scarring;
D O I
10.1097/ICO.0b013e318157a111
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To analyze the indications and outcomes of phototherapeutic keratectomy (PTK) in the developing world. Methods: In this retrospective study, the records of 203 consecutive eyes of 191 patients who had undergone PTK at a tertiary eye care center were evaluated. The parameters assessed were indications of PTK, demographic features, best spectacle-corrected visual acuity (BSCVA), and pachymetry. PTK was done by using a 193-nm Ar-F Excimer laser (Chiron Technolas Keracor 217 C) in a 6-mm optic zone. Patients were followed up for 6 months. Results: The most common indication of PTK was symptomatic bullous keratopathy (103 eyes). The patients were divided into 2 groups: those with bullous keratopathy (PTK BK) and those with superficial corneal pathologies (PTK CS). In the PTK CS group, the most common indications were Salzmann nodular degeneration (n = 27) and spheroidal degeneration (n = 22). BSCVA improved from 20/222 (0.09) to 20/86 (0.23) in the PTK CS group and 20/384 (0.05) to 20/202 (0.09) in the PTK BK group (P < 0.0001 in both groups). There was a significant decrease in the number of patients with severe symptoms in the PTK-BK (P < 0.0001) and PTK-CS (P = 0.017) groups. The change in BSCVA was significantly related to both pre-PTK BSCVA and pachymetry in PTK-BK. Conclusions: PTK is an efficacious treatment modality for symptomatic relief and visual gain in cases with superficial corneal involvement and bullous keratopathy.
引用
收藏
页码:44 / 49
页数:6
相关论文
共 23 条
[1]   EFFECTIVE CORNEAL RETRIEVAL IN A GENERAL-HOSPITAL - THE ROYAL-MELBOURNE-HOSPITAL EYE BANK [J].
CHOPRA, GK ;
DEVINCENTIS, F ;
KAUFMAN, D ;
COLLIE, D .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY, 1993, 21 (04) :251-255
[2]   Shallow ablations in phototherapeutic keratectomy: Long-term follow-up [J].
Chow, AMM ;
Yiu, EPF ;
Hui, MK ;
Ho, CK .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2005, 31 (11) :2133-2136
[3]  
DAUSCH D, 1993, REFRACT CORNEAL SURG, V9, P419
[4]   Refractive changes after excimer laser phototherapeutic keratectomy [J].
Dogru, M ;
Katakami, C ;
Yamanaka, A .
JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2001, 27 (05) :686-692
[5]  
Fagerholm P, 1993, Refract Corneal Surg, V9, pS76
[6]   Phototherapeutic keratectomy: 12 years of experience [J].
Fagerholm, P .
ACTA OPHTHALMOLOGICA SCANDINAVICA, 2003, 81 (01) :19-32
[7]   Therapeutic use of the 193-nm excimer laser in corneal pathologies [J].
Forster, W ;
Atzler, U ;
Ratkay, I ;
Busse, H .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1997, 235 (05) :296-305
[8]   Rates of potential and actual cornea donation in a general hospital: Impact of exhaustive death screening and surrogate phone consent [J].
Geissler, A ;
Paoli, K ;
Maitrejean, C ;
Durand-Gasselin, J .
TRANSPLANTATION PROCEEDINGS, 2004, 36 (10) :2894-2895
[9]  
Lee Eun Suk, 2003, Curr Opin Ophthalmol, V14, P186, DOI 10.1097/00055735-200308000-00003
[10]   Phototherapeutic keratectomy in treating keratomycosis [J].
Lin, CP ;
Chang, CW ;
Su, CY .
CORNEA, 2005, 24 (03) :262-268